Cannabis News Box

GW Pharmaceuticals turns over $108M in Q4 sales thanks to CBD-based medicine

https://globenewswire.com/news-release/2018/06/25/1529165/0/en/GW-Pharmaceuticals-plc-and-its-U-S-Subsidiary-Greenwich-Biosciences-Announce-FDA-Approval-of-EPIDIOLEX-cannabidiol-oral-solution-the-First-Plant-derived-Cannabinoid-Prescription-Me.html

Bethan Rose Jenkins, Cannabis News Writer/Editorial

January 27, 2020

Following the EU approval of a cannabis-derived epilepsy treatment called Epidiolex, British drugs company GW Pharmaceuticals is experiencing a major surge in sales. Headquartered in London, GW Pharma recently revealed its latest sales figures to investors; $108 million during the last quarter of 20...

nabiximols